Microbiome: Correlation between Gut Microbiome and Response to Immunotherapy in Cancer Patients.

Sparrow and MSU feasibility study to establish the relationship between the success/failure of checkpoint inhibitor therapy and gut biome of cancer patients. Adults prior to starting immunotherapy or healthy adult volunteers.
Contact phone
Nurse - Tracy | 517.364.2835
Principal investigator
Dr. Gordan Srkalovic, MD, PhD
Trial Category
Trial SubCategory
All tumor types